It's a victory for Mourenx and the company Novasep, which has just been chosen by Pfizer to produce its anti-Covid pill.
This was announced by the American laboratory, already a customer of the French company, indicating that it wanted to invest 520 million euros over five years in France for the production of Paxlovid, which obtained the green light from the High Authority for Health. (HAS) this Friday, and in peak research.
Read alsoThe boss of Pfizer at
Le Figaro
: “We will soon resume normal life”
The Novasep factory, located in this town in the Pyrénées-Atlantiques, will manufacture the active ingredient of the drug intended to reduce the severity of the disease but also the probability of infection after exposure, in addition to the vaccine.
“This is excellent news for the group and for all patients with Covid who will benefit from very effective treatment”
, reacts, with Le
Figaro
, Michel Spagnol, chairman and CEO of Novasep which has five sites, 1250 employees, including 850 in France.
Production, which could start from the third quarter of 2022…
This article is for subscribers only.
You have 80% left to discover.
Cultivating your freedom is cultivating your curiosity.
Keep reading your article for 1€ the first month
I ENJOY IT
Already subscribed?
Login
